Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis

Background: Chronic pulmonary diseases are characterized by airway remodeling due to complex multicellular responses and the production of free oxygen radicals. They lead to a progressive decline of pulmonary functions. Adelmidrol is an analogue of palmitoylethanolamide (PEA), which is a well-known...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antioxidants (Basel)
Glavni autori: Fusco, Roberta, Cordaro, Marika, Genovese, Tiziana, Impellizzeri, Daniela, Siracusa, Rosalba, Gugliandolo, Enrico, Peritore, Alessio Filippo, D’Amico, Ramona, Crupi, Rosalia, Cuzzocrea, Salvatore, Di Paola, Rosanna
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7402091/
https://ncbi.nlm.nih.gov/pubmed/32660140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox9070601
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items